The prognostic impact of human epidermal growth factor receptor 2 (HER2) status in metastatic colorectal cancer (mCRC)

被引：0
|
作者：
Starling, N. [1 ]
Snider, J. [2 ]
Cho-Phan, C. [2 ]
Wang, J. [2 ]
Martin, P. [3 ]
Simon, C. [3 ]
Bartley, K. [4 ]
机构：
[1] Royal Marsen NHS Fdn Trust, Gastrointestinal Unit, Surrey, England
[2] Flatiron Hlth, New York, NY USA
[3] Pfizer Inc, Med Affairs, Sandwich, Kent, England
[4] Pfizer Inc, Hlth Econ & Outcomes Res, San Francisco, CA USA
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.086
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
75P
引用
收藏
页码：S36 / S37
页数：2
相关论文
共 50 条
  • [1] Expression of the epidermal growth factor receptor (EGFR or HER1) and human epidermal growth factor receptor 2 (HER2) in a large scale metastatic colorectal cancer (mCRC) trial.
    Adenis, A
    Aguilar, EA
    Robin, YM
    Miquel, R
    Penault-Llorca, F
    Castañón, C
    Queralt, B
    Eggleton, SP
    van den Berg, N
    Wilke, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 278S - 278S
  • [2] Focus on human epidermal growth factor receptor 2 (HER2) positive metastatic colorectal cancer (HER2+mCRC): A real world retrospective analysis
    Calegari, Maria Alessandra
    Formica, Vincenzo
    Zoratto, Federica
    Arrivi, Giulia
    Torsello, Angela
    Polito, Mariam Grazia
    Vincenzo, Picone
    Emiliani, Alessandra
    Cereda, Vittore
    Schirripa, Marta
    Caira, Giulia
    Spring, Alexia
    Chiofalo, Laura
    Morelli, Cristina
    Missori, Francesca
    Spoto, Chiara
    Mazzuca, Federica
    Artemi, Adele
    Dell'Aquila, Emanuela
    Salvatore, Lisa
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer
    Siena, S.
    Sartore-Bianchi, A.
    Marsoni, S.
    Hurwitz, H. I.
    McCall, S. J.
    Penault-Llorca, F.
    Srock, S.
    Bardelli, A.
    Trusolino, L.
    ANNALS OF ONCOLOGY, 2018, 29 (05) : 1108 - 1119
  • [4] The human epidermal growth factor receptor 2 (HER2)
    Tafe, Laura J.
    Tsongalis, Gregory J.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (01) : 23 - 30
  • [5] The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker
    Cooke, T
    Reeves, J
    Lannigan, A
    Stanton, P
    EUROPEAN JOURNAL OF CANCER, 2001, 37 : S3 - S10
  • [6] Human epidermal growth factor receptor 2 (HER2) status in breast cancer: practice points and challenges
    Laokulrath, Natthawadee
    Gudi, Mihir
    Salahuddin, Syed Ahmed
    Chong, Angela Phek Yoon
    Ding, Cristine
    Iqbal, Jabed
    Leow, Wei Qiang
    Tan, Benjamin Yongcheng
    Tse, Gary
    Rakha, Emad
    Tan, Puay Hoon
    HISTOPATHOLOGY, 2024, 85 (03) : 371 - 382
  • [7] An Audit of Hormone Receptor and Human Epidermal Growth Factor Receptor-2 (HER2) Status in Breast Carcinoma Metastatic to Bone
    Gardner, K.
    Loane, J.
    JOURNAL OF PATHOLOGY, 2021, 255 : S44 - S44
  • [8] Impact of Human Epidermal Growth Factor Receptor 2 (HER2) Low Status in Response to Neoadjuvant Chemotherapy in Early Breast Cancer
    Alves, Fatima R.
    Gil, Lucia
    de Matos, Leonor Vasconcelos
    Baleiras, Ana
    Vasques, Carolina
    Neves, Maria Teresa
    Ferreira, Andre
    Fontes-Sousa, Mario
    Miranda, Helena
    Martins, Ana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [9] Clinical impact of epidermal growth factor receptor (EGFR) coexpression in early breast cancer with human epidermal growth factor receptor 2 (HER2) overexpression
    Park, S.
    Cho, E.
    Shin, Y.
    Hong, S.
    Lee, M.
    Park, Y.
    Nam, S.
    Yang, J.
    Choi, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Impact of the Updated Guidelines on Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer
    Kim, Min Chong
    Kang, Su Hwan
    Choi, Jung Eun
    Bae, Young Kyung
    JOURNAL OF BREAST CANCER, 2020, 23 (05) : 484 - 497
12345